Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

The National Cancer Institute (NCI) is seeking research project grant applications that integrate imaging and fluid-based tumor monitoring assays during cancer therapy in patients. The goal is to determine the optimal use of these modalities in characterizing therapy response and/or emergence of resistance. Eligible applicants include various organizations such as state governments, county governments, city or township governments, independent school districts, special district governments, and Native American tribal governments. Key aspects of the project include: • Integration of imaging and fluid-based tumor monitoring assays • Characterization of therapy response and emergence of resistance • Eligibility of various organizations as applicants • Funding opportunity for research projects